EP Patent

EP4230264A2 — Prodrugs of fumarates and their use in treating various deseases

Assigned to Alkermes Pharma Ireland Ltd · Expires 2023-08-23 · 3y expired

What this patent protects

The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.

USPTO Abstract

The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP4230264A2
Jurisdiction
EP
Classification
—
Expires
2023-08-23
Drug substance claim
No
Drug product claim
No
Assignee
Alkermes Pharma Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.